Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after

Epilepsia

Volumn 55, Issue 9, 2014, Pages 1452-1459

  Garcia, Hector H ^a,b,c   Gonzales, Isidro ^a   Lescano, Andres G ^b,d   Bustos, Javier A ^c   Pretell, E Javier ^e   Saavedra, Herbert ^a   Nash, Theodore E ^f  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c Universidad Peruana Cayetano Heredia   (Peru)

^d Virology Program   (Peru)

^e HOSPITAL NACIONAL ALBERTO SABOGAL SOLOGUREN   (Peru)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cestodes; Cysticercosis; Epilepsy; Neurocysticercosis; Peru; Seizures; Taenia solium

Indexed keywords

ALBENDAZOLE; DEXAMETHASONE; ANTIPARASITIC AGENT;

ABDOMINAL PAIN; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHINGOID SYNDROME; DEPRESSION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INSOMNIA; MALE; MOOD DISORDER; NAUSEA; NEUROCYSTICERCOSIS; NUMBERS NEEDED TO TREAT; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STEROID THERAPY; TONIC CLONIC SEIZURE; TREATMENT DURATION; VOMITING; ADOLESCENT; CESTODES; CONTROLLED CLINICAL TRIAL; CYSTICERCOSIS; ELECTROENCEPHALOGRAPHY; EPILEPSY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PERU; RETROSPECTIVE STUDY; SEIZURE; TAENIA SOLIUM; TIME; YOUNG ADULT;

CESTODES; CYSTICERCOSIS; EPILEPSY; NEUROCYSTICERCOSIS; PERU; SEIZURES; TAENIA SOLIUM;

ADOLESCENT; ADULT; ANTIPARASITIC AGENTS; CYSTICERCOSIS; DEXAMETHASONE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; TIME FACTORS; YOUNG ADULT;

EID: 84908043520     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12739     Document Type: Article

References (22)

1. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005;4:653-661.
2. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 2011;7:584-594.
3. Escobar A. The pathology of neurocysticercosis. In Palacios E, Rodriguez-Carbajal J, Taveras JM (Eds) Cysticercosis of the central nervous system. Springfield: Charles C. Thomas, 1983:27-54.
4. Sotelo J, Escobedo F, Rodriguez-Carbajal J, et al. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310:1001-1007.
5. Ramos-Zúñiga R, Pérez-Gómez HR, Jáuregui-Huerta F, et al. Incidental consequences of antihelmintic treatment in the central nervous system. World Neurosurg 2013;79:149-153.
6. Spina-Franca A. Cerebrospinal fluid syndrome induced by neurocysticercosis. Arq Neuropsiquiatr 1961;19:307-314.
7. Nash TE, Mahanty S, Garcia HH. Corticosteroid use in neurocysticercosis. Expert Rev Neurother 2011;11:1175-1183.
8. Cuello-García CA, Roldán-Benítez YM, Pérez-Gaxiola G, et al. Corticosteroids for neurocysticercosis: a systematic review and metaanalysis of randomized controlled trials. Int J Infect Dis 2013;17:e583-e592.
9. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258.
10. Thurman DJ, Beghi E, Begley CE, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011;52(Suppl. 7):2-26.
11. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
12. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1050-1055.
13. Botero D, Uribe CS, Sanchez JL, et al. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 1993;87:576-577.
14. Mall RK, Agarwal A, Garg RK, et al. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003;44:1397-1401.
15. Garg RK, Potluri N, Kar AM, et al. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 2006;53:65-69.
16. Prakash S, Garg RK, Kar AM, et al. Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation. Seizure 2006;15:328-332.
17. Kishore D, Misra S. Short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercal granuloma with single small enhancing CT lesion: an open label randomized prospective study. J Assoc Phys India 2007;55:419-424.
18. Singla M, Prabhakar S, Modi M, et al. Short-course of prednisolone in solitary cysticercus granuloma: a randomized, double-blind, placebocontrolled trial. Epilepsia 2011;52:1914-1917.
19. Otte WM, Singla M, Sander JW, et al. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology 2013;80:152-162.
20. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465-470.
21. Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010;75: 2236-2245.
22. Rajshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 2001;57:2315-2317.